A clinical-stage biotech focusing on gene and cell therapies for heart disease.
: Strategic expansion in North America, including acquiring equity in major mining projects. Tenaya Therapeutics (TNYA) : ~$0.70
: Low trading volume means you might not be able to sell your shares at your desired price during a market downturn.
: Expion360 (XPON) focuses on lithium battery storage for recreational use, while Ondas Holdings (ONDS) provides industrial wireless data networks. Critical Risk Review for Long-Term Holding
: Maintained as a "Moderate Buy" by consensus, with significant upside price targets based on its genetic pipeline. Plus Therapeutics (PSTV) : ~$0.25
A clinical-stage biotech focusing on gene and cell therapies for heart disease.
: Strategic expansion in North America, including acquiring equity in major mining projects. Tenaya Therapeutics (TNYA) : ~$0.70 stocks under $1 to buy
: Low trading volume means you might not be able to sell your shares at your desired price during a market downturn. A clinical-stage biotech focusing on gene and cell
: Expion360 (XPON) focuses on lithium battery storage for recreational use, while Ondas Holdings (ONDS) provides industrial wireless data networks. Critical Risk Review for Long-Term Holding stocks under $1 to buy
: Maintained as a "Moderate Buy" by consensus, with significant upside price targets based on its genetic pipeline. Plus Therapeutics (PSTV) : ~$0.25
